Showing results (861-870 of 895) with videos related to

Sort By:
Pageof 90
Cell Chemical Biology|September 9, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolismKeene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Nature Genetics|June 2, 2025
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavageZheqi Li, Guillermo Peluffo, Laura E Stevens, et al.
Translational Stroke Research|August 23, 2023
A Transcriptomic Comparative Study of Cranial VasculatureJianing Zhang, Jee-Yeon Ryu, Selena-Rae Tirado, et al.
Cancer Discovery|September 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted CancersBrian Belmontes, Katherine K Slemmons, Chun Su, et al.
Thorax|May 12, 2021
Chronic airflow obstruction and ambient particulate air pollutionAndre F S Amaral, Peter G J Burney, Jaymini Patel, et al.
Nature Cancer|July 3, 2020
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profilingSteven M Corsello, Rohith T Nagari, Ryan D Spangler, et al.
Biological Psychiatry|December 23, 2023
Deep Brain Stimulation for Obsessive-Compulsive Disorder: Optimal Stimulation SitesGarance M Meyer, Barbara Hollunder, Ningfei Li, et al.
Clinical and Translational Allergy|November 8, 2019
Helsinki by nature: The Nature Step to Respiratory HealthTari Haahtela, Leena von Hertzen, Josep M Anto, et al.
Nature|July 6, 2017
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathwayVasanthi S Viswanathan, Matthew J Ryan, Harshil D Dhruv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical ModelsDejan Juric, Kyung Song, Radia M Johnson, et al.
Pageof 90